UnitedHealth (1UNH) Stock Forecast & Price Target
1UNH Analyst Ratings
Strong Buy
14Buy3Hold0Sell
Based on 17 analysts giving stock ratings to UnitedHealth in the past 3 months
1UNH Stock 12 Month Forecast
Average Price Target
EUR 432.08â–˛(18.31% Upside)Based on 17 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is EUR 432.08 with a high forecast of EUR 475.32 and a low forecast of EUR 359.85. The average price target represents a 18.31% change from the last price of EUR 365.20.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 475.32
AverageEUR 432.08
LowEUR 359.85
Highest Price TargetHighestEUR 475.32Average Price TargetEUR 432.08Lowest Price TargetLowestEUR 359.85
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Stephen Baxter | Wells Fargo | EUR 470.85→EUR 435.94 | buy | 19.37%Upside | Reiterated | 10/27/26 | ||
| Erin Wright | Morgan Stanley | EUR 473.53→EUR 475.32 | buy | 30.15%Upside | Reiterated | 10/27/26 | ||
| Ann Hynes | Mizuho Securities | EUR 441.31→EUR 447.58 | buy | 22.56%Upside | Reiterated | 10/22/26 | ||
| Ben Hendrix | RBC Capital | EUR 427.88→EUR 445.78 | buy | 22.07%Upside | Assigned | 10/19/26 | ||
| Lance Wilkes | Bernstein | EUR 458.32→EUR 447.58 | buy | 22.56%Upside | Reiterated | 10/16/26 | ||
| Lisa Gill | J.P. Morgan | EUR 461.90→EUR 469.06 | buy | 28.44%Upside | Assigned | 10/16/26 | ||
| Whit Mayo | Leerink Partners | EUR 422.51 | buy | 15.69%Upside | Assigned | 10/15/26 | ||
| Ryan Langston | TD Cowen | EUR 359.85 | hold | -1.46%Downside | Reiterated | 10/15/26 | ||
| Parker Snure | Raymond James | EUR 425.20→EUR 402.82 | buy | 10.30%Upside | Reiterated | 10/15/26 | ||
| Andrew Mok CFA | Barclays | EUR 394.76→EUR 393.87 | buy | 7.85%Upside | Reiterated | 10/14/26 | ||
| Kevin Fischbeck | Bank of America Securities | EUR 458.32 | buy | 25.50%Upside | Reiterated | 10/14/26 | ||
| Jessica Tassan | Piper Sandler | EUR 449.37→EUR 451.16 | buy | 23.54%Upside | Reiterated | 10/14/26 | ||
| Michael Ha | Robert W. Baird | EUR 405.50→EUR 382.23 | hold | 4.66%Upside | Reiterated | 10/14/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | EUR 429.67 | buy | 17.65%Upside | Reiterated | 10/13/26 | ||
| Scott Fidel | Goldman Sachs | EUR 438.62→EUR 452.95 | buy | 24.03%Upside | Reiterated | 10/13/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Stephen Baxter | 10/27/26 | EUR 470.85→EUR 435.94 | buy | 19.37%Upside | Reiterated | Wells Fargo | ||
| Erin Wright | 10/27/26 | EUR 473.53→EUR 475.32 | buy | 30.15%Upside | Reiterated | Morgan Stanley | ||
| Ann Hynes | 10/22/26 | EUR 441.31→EUR 447.58 | buy | 22.56%Upside | Reiterated | Mizuho Securities | ||
| Ben Hendrix | 10/19/26 | EUR 427.88→EUR 445.78 | buy | 22.07%Upside | Assigned | RBC Capital | ||
| Lance Wilkes | 10/16/26 | EUR 458.32→EUR 447.58 | buy | 22.56%Upside | Reiterated | Bernstein | ||
| Lisa Gill | 10/16/26 | EUR 461.90→EUR 469.06 | buy | 28.44%Upside | Assigned | J.P. Morgan | ||
| Whit Mayo | 10/15/26 | EUR 422.51 | buy | 15.69%Upside | Assigned | Leerink Partners | ||
| Ryan Langston | 10/15/26 | EUR 359.85 | hold | -1.46%Downside | Reiterated | TD Cowen | ||
| Parker Snure | 10/15/26 | EUR 425.20→EUR 402.82 | buy | 10.30%Upside | Reiterated | Raymond James | ||
| Andrew Mok CFA | 10/14/26 | EUR 394.76→EUR 393.87 | buy | 7.85%Upside | Reiterated | Barclays | ||
| Kevin Fischbeck | 10/14/26 | EUR 458.32 | buy | 25.50%Upside | Reiterated | Bank of America Securities | ||
| Jessica Tassan | 10/14/26 | EUR 449.37→EUR 451.16 | buy | 23.54%Upside | Reiterated | Piper Sandler | ||
| Michael Ha | 10/14/26 | EUR 405.50→EUR 382.23 | hold | 4.66%Upside | Reiterated | Robert W. Baird | ||
| Elizabeth Anderson CFA | 10/13/26 | EUR 429.67 | buy | 17.65%Upside | Reiterated | Evercore ISI | ||
| Scott Fidel | 10/13/26 | EUR 438.62→EUR 452.95 | buy | 24.03%Upside | Reiterated | Goldman Sachs |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering UnitedHealth
3 Months
Success Rate34/49 ratings generated profit
69%
Average Return
+6.50%
Copying A.J. Rice's trades and holding each position for 3 Months would result in 69.39% of your transactions generating a profit, with an average return of +6.50% per trade.
1 Year
Success Rate39/47 ratings generated profit
83%
Average Return
+20.84%
Copying Scott Fidel's trades and holding each position for 1 Year would result in 82.98% of your transactions generating a profit, with an average return of +20.84% per trade.
2 Years
Success Rate44/49 ratings generated profit
90%
Average Return
+43.41%
Copying A.J. Rice's trades and holding each position for 2 Years would result in 89.80% of your transactions generating a profit, with an average return of +43.41% per trade.
1UNH Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 40 | 34 | 28 | 27 | 28 |
| Hold | 8 | 5 | 6 | 6 | 6 |
| Sell | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 49 | 39 | 34 | 33 | 34 |
In the current month, 1UNH has received 28 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. 1UNH average Analyst price target in the past 3 months is 432.08.
1UNH Financial Forecast
HighEUR 2.33
ConsensusEUR 2.03
LowEUR 1.92
1UNH Earnings Forecast
Next quarter’s earnings estimate for 1UNH is EUR 2.03 with a range of EUR 1.92 to EUR 2.33. The previous quarter’s EPS was EUR 4.18. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 103B
ConsensusEUR 100B
LowEUR 97.2B
1UNH Sales Forecast
Next quarter’s sales forecast for 1UNH is EUR 100.04B with a range of EUR 97.24B to EUR 102.83B. The previous quarter’s sales results were EUR 100.42B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
1UNH Stock Forecast FAQ
What is IT:1UNH’s average 12-month price target, according to analysts?
Based on analyst ratings, UnitedHealth’s 12-month average price target is €432.08.
What is IT:1UNH’s upside potential, based on the analysts’ average price target?
UnitedHealth has 18.31% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is UnitedHealth a Buy, Sell or Hold?
UnitedHealth has a consensus rating of Strong Buy, which is based on 14 buy ratings, 3 hold ratings and 0 sell ratings.
What is UnitedHealth’s share price target?
The average share price target for UnitedHealth is €432.08. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €475.32, and the lowest forecast is €359.85. The average share price target represents a 18.31% increase from the current price of €365.2.
What do analysts say about UnitedHealth?
UnitedHealth’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of UnitedHealth?
To buy shares of IT:1UNH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
